REMICADE Antitrust Settlement Receives Final Approval
LexBlog IP
APRIL 12, 2023
In 2017, three indirect-purchaser antitrust class actions were filed against Johnson & Johnson and Janssen Biotech, Inc., The court preliminarily approved the settlement in August 2022. The post REMICADE Antitrust Settlement Receives Final Approval appeared first on Big Molecule Watch. million in expenses.
Let's personalize your content